The bacteria could present a "novel biological control mechanism," aiding efforts to stop the spread of Zika virus, said Matthew Aliota from University of Wisconsin-Madison (UW-Madison) in the US.
Scientists believe that the Zika virus is responsible for a host of brain defects in developing foetuses, including microcephaly, and has contributed to an uptick in cases of a neurological disorder called Guillain-Barre syndrome.
There are not yet any approved Zika virus vaccines or antiviral medications, and ongoing mosquito control strategies have not been adequate to contain the spread of the virus.
Wolbachia can be found in up to 60 per cent of insects around the world, including butterflies and bees. While not typically found in the Aedes aegypti mosquito - the species also transmits dengue, chikungunya and yellow fever viruses.
More From This Section
Scott O'Neill from Monash University in Australia discovered in the 1990s that Wolbachia could be introduced to the mosquito in the lab and would prevent the mosquitoes from transmitting dengue virus.
The mosquitoes were either harbouring the same strain of the Wolbachia bacteria (called wMel) used in field studies or were Wolbachia-free and the mice had levels of virus in their blood similar to humans infected with Zika virus.
An additional group of mosquitoes, both wild-type and Wolbachia-infected, was allowed to feed instead from a membrane containing sheep's blood spiked with a high concentration of Zika virus, per other standard laboratory studies, researchers said.
They found that mosquitoes carrying Wolbachia were less likely to become infected with Zika virus after feeding on viral blood, and those that were infected were not capable of transmitting the virus in their saliva.
"We saw reduced vector competence in Aedes aegypti with Wolbachia. Mosquitoes with Wolbachia were less capable of harbouring Zika virus, and though they do get infected with Zika, it is to a lesser extent than wild-type mosquitoes," said Jorge Osorio from UW-Madison.